To find the latest CAP resources on the coronavirus, visit our coronavirus resource page.
President Donald Trump promised to provide the experimental drug he took — a cocktail of monoclonal antibodies developed by Regeneron — for free to anyone who needs it. But as a result of his administration’s failure to harness the tools of government and the private sector, extreme rationing of the treatment will occur.
Monoclonal antibodies are genetically engineered antibodies that could both treat and prevent COVID-19 infection. Regeneron reported promising preliminary results and applied for an emergency use authorization from the Food and Drug Administration. Monoclonal antibodies could be effective for populations for whom a vaccine is not authorized or effective. And because no vaccine will be 100% effective, a therapeutic is still very much needed.The above excerpt was originally published in USA Today. Please click here to view the full op-ed.